Test blood biomarkers to help diagnose concussion
Part of Brain & nervous system, Injuries & trauma clinical trials.
This study checks whether a blood test can accurately and quickly identify an uncomplicated concussion. It may help doctors confirm concussion sooner and more reliably, and potentially reduce time and cost of diagnosis.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Have an uncomplicated concussion diagnosis with a normal brain scan (no intracranial abnormalities)
- Be 18 to 65 years old
- OR, if not a concussion: have a musculoskeletal (muscle or joint) injury with no other major health problems
- Have no history of moderate or severe brain injury (including complicated mild traumatic brain injury)
- Do not have other neurological problems (like stroke, seizures, or dementia) or major metabolic/organ diseases (like uncontrolled diabetes, liver, kidney, or significant heart conditions)
- Join within 7 days of the injury (or earlier)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how athletes recover from concussions or mild traumatic brain injuries. It aims to understand recovery patterns, which could help improve care for sports-related head injuries.
This study is testing whether a quick eye-tracking test, along with a blood test, can tell doctors if you need a head CT scan after a mild brain injury and help predict how quickly you'll recover.
This study is looking for people with a recent traumatic brain injury (within 24 hours) to see if testing certain proteins in the blood can help doctors better diagnose and treat the injury.
This study uses a blood test to help doctors better understand and manage mild traumatic brain injury (concussion). If you had a mild head injury in the past 12 hours and have certain symptoms, researchers want to check if a new blood-based approach can improve care.
This study uses MRI scans and blood tests to measure brain recovery after a concussion. It will help doctors understand how concussions affect the brain and find better ways to diagnose them.
This study checks whether two blood proteins (GFAP and UCH-L1) can help identify which brain spots are linked to a significant head injury after a concussion. You may be able to help by providing a blood sample and getting a CT scan as part of usual care, so doctors can better sort out injury risk.
Hear when a new Concussion, Mild trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.